L. Lessard

Involvement of Type I Interferon Signaling in Muscle Stem Cell Proliferation During Dermatomyositis

B. Chazaud, R. Mounier, G. Mouchiroud, 2022, Neurology.

Input of Major Histocompatibility Complex class II immunostaining in idiopathic inflammatory myopathies

M. Robert, A. Hot, B. Chazaud, 2022, medRxiv.

Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies

F. Bouhour, R. Marignier, E. Delmont, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry.

F. Bérard, G. Bassez, D. Orlikowski, 2023, Molecular genetics and metabolism.

Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin

F. Authier, M. Robert, A. Hot, 2022, Rheumatology.

Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy

S. Thobois, F. Bouhour, S. Gerber, 2023, EMBO molecular medicine.

Myalgia, Headaches, and Ineffective Immunosuppressive Drugs in a 65-Year-Old Female With Rheumatoid Arthritis.

H. Lepidi, N. Streichenberger, C. Compain, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study

I. Durieu, P. Petiot, M. Robert, 2023, Rheumatology.

The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis

J. Senderek, T. Nonaka, Edwige Belotti, 2023, Brain : a journal of neurology.